Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201104322 Principal Investigator: Grigsby, Perry
Title: FDG Tumor Heterogeneity during Chemoradiation as a Predictor of Response to Concurrent Radiation Therapy and Chemotherapy in Patients with Cervical Cancer
Phase: Pilot Disease Site: Cervix
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this research study is to see if positron emission tomography (PET imaging) with 18Ffluorodeoxyglucose (FDG – a radioactive form of sugar) can help doctors determine which patients will respond best to traditional treatment versus those that need more aggressive therapy to prevent their
disease from coming back. Previous research studies here at Washington University have shown that FDG-PET imaging can predict whether or not cancer has spread outside the cervix as well as predicting disease returning after finishing chemoradiation.
 
More Information:
ClinicalTrials.gov Entry
Internal Protocol Documents (requires Siteman administrative database password)